Showing results (41-50 of 86) with videos related to
Sort By:
Pageof 9
Biological & Pharmaceutical Bulletin|October 6, 2012
Leishmanicidal activity of two naphthoquinones against Leishmania donovaniClaudio Manuel Lezama-Dávila, Angelica Patricia Isaac-Márquez, Govind Kapadia, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2013
The pore-forming toxin listeriolysin O is degraded by neutrophil metalloproteinase-8 and fails to mediate Listeria monocytogenes intracellular survival in neutrophilsEusondia Arnett, Stephen Vadia, Colleen C Nackerman, et al.The Journal of Infectious Diseases|May 2, 2007
Lack of CXCR3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovaniJoseph Barbi, Steve Oghumu, Lucia E Rosas, et al.Cancers|July 14, 2023
Ionizing Radiation Reduces Head and Neck Squamous Cell Carcinoma Cell Viability and Is Associated with Predictive Tumor-Specific T Cell ResponsesPuja Upadhaya, Nathan Ryan, Peyton Roth, et al.British Journal of Cancer|May 20, 2022
STAT1 is regulated by TRIM24 and promotes immunosuppression in head and neck squamous carcinoma cells, but enhances T cell antitumour immunity in the tumour microenvironmentKelvin Anderson, Nathan Ryan, Divya Nedungadi, et al.Immunology|April 1, 2014
CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer modelSteve Oghumu, Sanjay Varikuti, Cesar Terrazas, et al.European Journal of Immunology|November 19, 2013
STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasisSteve Oghumu, Gaurav Gupta, Heidi M Snider, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|December 14, 2011
Pulmonary T cell activation in response to chronic particulate air pollutionJeffrey A Deiuliis, Thomas Kampfrath, Jixin Zhong, et al.Blood|July 29, 2008
PI3Kgamma (PI3Kgamma) is essential for efficient induction of CXCR3 on activated T cellsJoseph Barbi, Hannah E Cummings, Bao Lu, et al.Oncoimmunology|March 18, 2025
Efficacy of anti-LAG3 and anti-PD-1 combination checkpoint inhibitor therapy against head and neck squamous cell carcinoma in a genetically engineered mouse modelFelipe F Lamenza, Peyton Roth, Puja Upadhaya, et al.Pageof 9